We are live on
!
Find out more
GA
Gagnon Advisors Portfolio holdings
AUM
$136M
1-Year Est. Return
21.55%
This Fund
S&P 500
This Quarter
Est. Return
+13.46%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$148M
AUM Growth
-$6.27M
(-4.1%)
Cap. Flow
-$9.94M
Cap. Flow
% of AUM
-6.71%
Top 10 Holdings %
Top 10 Hldgs %
60.03%
Holding
32
New
–
Increased
3
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$1.52M |
| 2 |
FIVE9
FIVN
|
+$992K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZUO
Zuora, Inc.
ZUO
|
+$2.97M |
| 2 |
Yext
YEXT
|
+$2.87M |
| 3 |
Heron Therapeutics
HRTX
|
+$2.43M |
| 4 |
LL
LL Flooring Holdings, Inc.
LL
|
+$2.13M |
| 5 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$1.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.39% |
| 2 | Healthcare | 27% |
| 3 | Industrials | 18.93% |
| 4 | Energy | 13.84% |
| 5 | Real Estate | 3.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETWO.WS
26
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
| $236K | 0.16% |
280,328
-219,490
| -44% | -$184K |
|
27
GeneDx Holdings
WGS
$2.05B
| $195K | 0.13% |
22,397
| – | – |
|
|
SLGCW
28
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $41K | 0.03% |
102,594
| – | – |
|
|
29
Heron Therapeutics
HRTX
$94.1M
| – | – |
-576,206
| Closed | -$2.43M |
|
|
WGSWW
30
DELISTED
GeneDx Holdings Warrant
WGSWW
| – | – |
-246,365
| Closed | -$56K |
|
|
LL
31
DELISTED
LL Flooring Holdings, Inc.
LL
| – | – |
-307,506
| Closed | -$2.13M |
|
Similar funds
WF
MWA
SSCM
BDCMI
WA
LCM
NVCHI
GPWA
Gagnon Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Gagnon Advisors held 32 positions worth $148M, down 4.1% from $154M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Gagnon Advisors withdrew a net $9.94M in Q4 2022, closing 3 positions and reducing 5 holdings. Its most notable exit was Heron Therapeutics, an estimated $2.43M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Gagnon Advisors added an estimated $1.52M to CareDx.
- Gagnon Advisors added most to CareDx in Q4 2022, an estimated $1.52M increase.
- Gagnon Advisors's biggest Q4 2022 reduction was Zuora, Inc., cutting an estimated $2.97M.
- Gagnon Advisors fully exited Heron Therapeutics in Q4 2022, selling an estimated $2.43M.
- Gagnon Advisors's ten largest holdings make up 60% of its $148M portfolio in Q4 2022.
- Gagnon Advisors opened 0 new positions and closed 3 in Q4 2022.
- Gagnon Advisors's portfolio value fell 4.1% quarter-over-quarter to $148M.
Based on Gagnon Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.